Novel compounds in preclinical/early clinical development for the treatment of HIV infections.
about
Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA.Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistanceHepatitis B and hepatitis C co-infection in patients with HIV.Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection.The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets.High throughput screening for cyanovirin-N mimetics binding to HIV-1 gp41.Antiviral drugs with extra-cellular sites of action.Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.Topochemical models for prediction of anti-HIV activity of 4-benzyl pyridinone derivatives.New barbiturates and thiobarbiturates as potential enzyme inhibitors.Polyoxometalates as Versatile Enzyme Inhibitors
P2860
Q33853034-B803F17C-8775-4058-8572-13BFDF37DE72Q34180538-D539CDB8-4F00-483E-A611-E9D6DB36DD0BQ34323219-C439F635-5C1E-4E4D-9385-62A7FA23B39CQ34481618-23FB4455-F922-48CA-9590-AA89364DA6B3Q35917148-32182AC2-5671-43C1-8956-DFCF6B29C3E4Q40732790-276A2598-9FA4-466E-9170-678BE17FCE14Q43759388-5FE459F2-727A-4FD8-B504-6163843E61ACQ44854785-BD578707-4109-43BB-AEEB-6A8662044FDAQ51959150-6E616A65-B0BE-4989-B22A-B20716A6AFC1Q55057836-EA0C4153-CFA5-4558-AAD4-30D03A9CD5A4Q57599139-E0146FB2-2E52-442A-B8C8-9B0C1F08AB90
P2860
Novel compounds in preclinical/early clinical development for the treatment of HIV infections.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Novel compounds in preclinical ...... e treatment of HIV infections.
@ast
Novel compounds in preclinical ...... e treatment of HIV infections.
@en
type
label
Novel compounds in preclinical ...... e treatment of HIV infections.
@ast
Novel compounds in preclinical ...... e treatment of HIV infections.
@en
prefLabel
Novel compounds in preclinical ...... e treatment of HIV infections.
@ast
Novel compounds in preclinical ...... e treatment of HIV infections.
@en
P2860
P1476
Novel compounds in preclinical ...... e treatment of HIV infections.
@en
P2093
De Clercq E
P2860
P304
P356
10.1002/1099-1654(200007/08)10:4<255::AID-RMV282>3.0.CO;2-6
P577
2000-07-01T00:00:00Z